Literature DB >> 28746723

Factors Associated With Achieving a Body Mass Index of Less Than 30 After Bariatric Surgery.

Oliver A Varban1, Ruth B Cassidy2, Aaron Bonham2, Arthur M Carlin3,4, Amir Ghaferi2, Jonathan F Finks1,2.   

Abstract

IMPORTANCE: Achieving a body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) of less than 30 is an important goal of bariatric surgery, given the increased risk for weight-related morbidity and mortality with a BMI above this threshold.
OBJECTIVE: To identify predictors for achieving a BMI of less than 30 after bariatric surgery. DESIGN, SETTING, AND PARTICIPANTS: This retrospective study used data from the Michigan Bariatric Surgery Collaborative, a statewide quality improvement collaborative that uses a prospectively gathered clinical data registry. A total of 27 320 adults undergoing primary bariatric surgery between June 2006 and May 2015 at teaching and nonteaching hospitals in Michigan were included. EXPOSURE: Bariatric surgery. MAIN OUTCOMES AND MEASURES: Logistic regression was used to identify predictors for achieving a BMI of less than 30 at 1 year after surgery. Secondary outcome measures included 30-day postoperative complications and 1-year self-reported comorbidity remission.
RESULTS: A total of 9713 patients (36%; mean [SD] age, 46.9 [11.3] years; 16.6% male) achieved a BMI of less than 30 at 1 year after bariatric surgery. A significant predictor for achieving this goal was a preoperative BMI of less than 40 (odds ratio [OR], 12.88; 95% CI, 11.71-14.16; P < .001). Patients who had a sleeve gastrectomy, gastric bypass, or duodenal switch were more likely to achieve a BMI of less than 30 compared with those who underwent adjustable gastric banding (OR, 8.37 [95% CI, 7.44-9.43]; OR, 21.43 [95% CI, 18.98-24.19]; and OR, 82.93 [95% CI, 59.78-115.03], respectively; P < .001). Only 8.5% of patients with a BMI greater than 50 achieved a BMI of less than 30 after bariatric surgery. Patients who achieved a BMI of less than 30 had significantly higher reported rates of medication discontinuation for hyperlipidemia (60.7% vs 43.2%, P < .001), diabetes (insulin: 67.7% vs 50.0%, P < .001; oral medications: 78.5% vs 64.3%, P < .001), and hypertension (54.7% vs 34.6%, P < .001), as well as a significantly higher rate of sleep apnea remission (72.5% vs 49.3%, P < .001) and higher satisfaction rate (92.8% vs 78.0%, P < .001) compared with patients who did not. CONCLUSIONS AND RELEVANCE: Patients with a preoperative BMI of less than 40 are more likely to achieve a BMI of less than 30 after bariatric surgery and are more likely to experience comorbidity remission. Policies and practice patterns that delay bariatric surgery until the BMI is 50 or greater can result in significantly inferior outcomes.

Entities:  

Mesh:

Year:  2017        PMID: 28746723      PMCID: PMC5710420          DOI: 10.1001/jamasurg.2017.2348

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  33 in total

Review 1.  Surgical treatment of obesity.

Authors:  Nancy Puzziferri; Jeanne Blankenship; Bruce M Wolfe
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Predictors of success after laparoscopic gastric bypass: a multivariate analysis of socioeconomic factors.

Authors:  R Lutfi; A Torquati; N Sekhar; W O Richards
Journal:  Surg Endosc       Date:  2006-05-02       Impact factor: 4.584

3.  Probability of an Obese Person Attaining Normal Body Weight: Cohort Study Using Electronic Health Records.

Authors:  Alison Fildes; Judith Charlton; Caroline Rudisill; Peter Littlejohns; A Toby Prevost; Martin C Gulliford
Journal:  Am J Public Health       Date:  2015-07-16       Impact factor: 9.308

Review 4.  American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery.

Authors:  Julie Kim; Dan Eisenberg; Dan Azagury; Ann Rogers; Guilherme M Campos
Journal:  Surg Obes Relat Dis       Date:  2015-11-27       Impact factor: 4.734

5.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

6.  Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery.

Authors:  Emilio Ortega; Rosa Morínigo; Lilliam Flores; Violeta Moize; Martin Rios; Antonio M Lacy; Josep Vidal
Journal:  Surg Endosc       Date:  2012-01-11       Impact factor: 4.584

7.  Perceived barriers to bariatric surgery among morbidly obese patients.

Authors:  Bianca B Afonso; Raul Rosenthal; Ka Ming Li; Jorge Zapatier; Samuel Szomstein
Journal:  Surg Obes Relat Dis       Date:  2009-10-03       Impact factor: 4.734

Review 8.  Patient and Referring Practitioner Characteristics Associated With the Likelihood of Undergoing Bariatric Surgery: A Systematic Review.

Authors:  Luke M Funk; Sally Jolles; Laura E Fischer; Corrine I Voils
Journal:  JAMA Surg       Date:  2015-10       Impact factor: 14.766

9.  Tipping point: factors influencing a patient's decision to proceed with bariatric surgery.

Authors:  Donna W Roberson; Janice A Neil; Mary Lisa Pories; Mary Ann Rose
Journal:  Surg Obes Relat Dis       Date:  2016-03-07       Impact factor: 4.734

Review 10.  Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist's perspective.

Authors:  Sonali Ganguly; Hong Chang Tan; Phong Ching Lee; Kwang Wei Tham
Journal:  J Biomed Res       Date:  2015-03-03
View more
  9 in total

1.  Overall Treatment Satisfaction 5 Years After Bariatric Surgery.

Authors:  Pål André Hegland; Anny Aasprang; Ronette L Kolotkin; Grethe S Tell; John Roger Andersen
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

2.  Bariatric Embolization of the Left Gastric Arteries for the Treatment of Obesity: 9-Month Data in 5 Patients.

Authors:  Zhi-Bin Bai; Yong-Lin Qin; Gang Deng; Guo-Feng Zhao; Bin-Yan Zhong; Gao-Jun Teng
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

3.  Weight loss before bariatric surgery and its impact on poor versus excellent outcomes at 2 years.

Authors:  Fernando Rodríguez; Antonio Herrera; Elisa M Sepúlveda; Lizbeth Guilbert; Louis A Hernández; Luis F Peñuñuri; Fátima M Rodríguez; Carlos Zerrweck
Journal:  Langenbecks Arch Surg       Date:  2022-01-11       Impact factor: 3.445

4.  Single Anastomosis Duodenal Switch: 1-Year Outcomes.

Authors:  Daniel Cottam; Mitchell Roslin; Paul Enochs; Matthew Metz; Dana Portenier; Dennis Smith
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

5.  Mid-term bariatric surgery outcomes for obese patients: does weight matter?

Authors:  N Samuel; Q Jalal; A Gupta; Fak Mazari; P Vasas; S Balachandra
Journal:  Ann R Coll Surg Engl       Date:  2019-09-06       Impact factor: 1.891

6.  Revisional Surgery for Insufficient Loss or Regain of Weight After Roux-en-Y Gastric Bypass: Biliopancreatic Limb Length Matters.

Authors:  Marko Kraljević; Thomas Köstler; Julian Süsstrunk; Ioannis I Lazaridis; Amy Taheri; Urs Zingg; Tarik Delko
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

7.  Activation of PPARγ Protects Obese Mice from Acute Lung Injury by Inhibiting Endoplasmic Reticulum Stress and Promoting Mitochondrial Biogenesis.

Authors:  Yin Tang; Ke Wei; Ling Liu; Jingyue Ma; Siqi Wu; Wenjing Tang
Journal:  PPAR Res       Date:  2022-09-28       Impact factor: 4.385

Review 8.  Surgical treatment of obesity.

Authors:  Vance L Albaugh; Naji N Abumrad
Journal:  F1000Res       Date:  2018-05-21

9.  The effects of bariatric surgery on periconception maternal health: a systematic review and meta-analysis.

Authors:  Katinka M Snoek; Régine P M Steegers-Theunissen; Eric J Hazebroek; Sten P Willemsen; Sander Galjaard; Joop S E Laven; Sam Schoenmakers
Journal:  Hum Reprod Update       Date:  2021-10-18       Impact factor: 15.610

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.